Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Trimodality Therapy for Patients With Thymoma or Thymic Carcinoma at Significant Risk for Recurrence

NCT00387868 is registered in ClinicalTrials.gov with Valley Health System as lead sponsor.

NCT NCT00387868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00387868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Trimodality Therapy for Patients With Thymoma or Thymic Carcinoma at Significant Risk for Recurrence
Lead sponsor
Valley Health System
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2006
Completion date
November 30, 2014
Enrollment
21 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

thymoma